Sort
50,496 grants matching “lung cancer”
Characterization of FGFR4 mutations in Rhabdomyosarcoma
$389,303Javed Khan · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Chemoprevention of Lung Cancer with Anti-tumor B
$389,250Ming You · Washington University · R01 · FY2007 · AT
Determining the effects of bone morphogenetic protein receptor 2 (BMPR2) inhibition on neural stem cell neurogenesis and regulation of energy homeostasis in Alzheimerâs disease and cancer
$389,236John Langenfeld · Rbhs -Cancer Institute Of New Jersey · R01 · FY2020 · CA
MOCSLID-CCC
$389,229Donald P Tashkin · University Of California Los Angeles · R01 · FY2012 · HL
Linking Epigenetic-Therapy Induction of Inflammasome Signaling to Generation of a BRCAness Phenotype
$389,189Kenneth P Nephew · Coriell Institute For Medical Research · P50 · FY2023 · CA
Linking Epigenetic-Therapy Induction of Inflammasome Signaling to Generation of a BRCAness Phenotype
$389,189Kenneth P Nephew · Coriell Institute For Medical Research · P50 · FY2022 · CA
Adaptive glutathione responses to cigarette smoke in COPD
$389,160Brian J Day · National Jewish Health · R01 · FY2008 · HL
Multi-institutional validation of a multi-modal machine learning algorithm to predict and reduce acute care during cancer therapy
$389,126Julian Clint Hong · University Of California, San Francisco · R01 · FY2023 · CA
NIH resubmission Deyu Li - Etheno adductome and repair pathways
$389,123Deyu Li · University Of Rhode Island · R01 · FY2023 · GM
Mapping Gene Networks in Colon Cancer
$389,117Norman H Lee · George Washington University · R01 · FY2008 · CA
PEG-like Multimodal Nanoprobes for Imaging Enhanced Permeability Retention
$389,057Charalambos Kaittanis · Massachusetts General Hospital · R01 · FY2016 · EB
PEG-like Multimodal Nanoprobes for Imaging Enhanced Permeability Retention
$389,057Marc David Normandin · Massachusetts General Hospital · R01 · FY2017 · EB
(8) Genetics of Immune Related Adverse Events and Response to Immunotherapy
$389,055Elad Ziv · University Of California, San Francisco · R01 · FY2020 · CA
USING RANDOM RISK TO MOTIVATE SMOKING REDUCTION
$388,971Oregon Research Institute · R01 · FY2002 · CA
Community Outreach and Engagement
$388,917Ken A. Resnicow · University Of Michigan At Ann Arbor · P30 · FY2020 · CA
Community Outreach and Engagement
$388,917Ken A. Resnicow · University Of Michigan At Ann Arbor · P30 · FY2021 · CA
Community Outreach and Engagement
$388,915Ken A. Resnicow · University Of Michigan At Ann Arbor · P30 · FY2019 · CA
Targeting Oncogenic KRAS with Brush-Architectured Poly(ethylene glycol)-DNA Conjugates
$388,910Ke Zhang · Northeastern University · R01 · FY2020 · CA
Project 3 Immunotherapeutic Targeting of SLC45A2 for Treatment of Uveal Melanoma
$388,908Cassian Yee · University Of Tx Md Anderson Can Ctr · P50 · FY2021 · CA
C MYC--TRANSCRIPTION AND APOPTOSIS
$388,896Johns Hopkins University · R37 · FY2003 · CA
A phase Ib/II study of AZD2171 and radiation for new brain metastases from NSCLC
$388,850April Fitzsimmons Eichler · Massachusetts General Hospital · R21 · FY2009 · CA
Community Outreach and Engagement
$388,838Lourdes Baezconde Garbanati · University Of Southern California · P30 · FY2025 · CA
Molecular Recognition during pre-mRNA Splicing
$388,819Clara L Kielkopf · University Of Rochester · R01 · FY2014 · GM
Molecular Recognition during pre-mRNA Splicing
$388,819Clara L Kielkopf · University Of Rochester · R01 · FY2016 · GM
Molecular Recognition during pre-mRNA Splicing
$388,819Clara L Kielkopf · University Of Rochester · R01 · FY2017 · GM